Project examines when patients can safely stop infliximab therapy without disease relapse, indicating effective management of neurosarcoidosis.
The objective of this project is to better characterize patients with neurosarcoidosis that are able to discontinue Infliximab therapy without disease relapse.
No takes yet. Share an insight, caveat, or question.
Maher et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: